Kim Forest Enterprise Co., Ltd. 6645
TWSE · Taiwan · Health Technology
TWD 12.75-0.10 (-0.78%)
Market open· · TWD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · TWD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
OMRON (TSE:6645) has drawn fresh attention after its recent share price moves, with the stock roughly flat over the past day but higher for the year to date and over the past 12 months. Short term momentum around OMRON has cooled, with a 30 day share price return down 4.64%. However, the 90 day move is up 11.89% and the 1 year total shareholder return is 58.25%, which points to strong longer term gains but more mixed recent sentiment. Scan beyond OMRON's recent momentum and line up other...
OMRON has logged a powerful share price run recently, which puts a spotlight on whether the current level is supported by what the company earns today. With the stock now trading at ¥6,325, the key issue is whether those earnings line up with the valuation investors are paying for. Year to date, OMRON is up 58.3%, which puts recent gains squarely up against the question of how much profit the business is currently generating. The group’s value hinges on how efficiently it can convert its...
Recent performance snapshot OMRON (TSE:6645) has drawn fresh attention after a period of mixed share performance, with the stock up around 4% over the past month but down about 8.5% over the past week. For investors tracking fundamentals, the company reports annual revenue of ¥767,351 and net income of ¥34,192, with recent year on year revenue growth of 5.16% and net income growth of 15.92%. See our latest analysis for OMRON. At a share price of ¥5,409, OMRON has seen short term momentum...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.